Blandford, Alexander D.Zhang, DaliaChundury, Rao V.Perry, Julian D.2018-05-312018-05-312017Blandford, A. D., Zhang, D., Chundury, R. V., & Perry, J. D. (2017). Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Review of Ophthalmology, 12(2), 111–121. http://doi.org/10.1080/17469899.2017.1276444https://hdl.handle.net/1805/16323INTRODUCTION: Dysthyroid optic neuropathy (DON) is a severe manifestation of thyroid eye disease (TED) that can result in permanent vision loss. Management is complex, multidisciplinary, and involves medical and/or surgical therapies. This review describes current concepts in the epidemiology, pathophysiology, diagnosis, and treatment of DON. AREAS COVERED: An extensive review of the literature was performed to detail current concepts on the diagnosis and management of DON. This includes utilization of various medical and surgical modalities for disease management. EXPERT COMMENTARY: DON can result in permanent blindness and often requires the use of corticosteroids and surgical decompression. We favor the use of intravenous corticosteroids and a transcaruncular approach when surgical decompression is indicated. The use of orbital radiation for DON is often reserved for patients that are poor surgical candidates and/or patients with refractory disease.en-USPublisher PolicyCompressive optic neuropathyDysthyroid optic neuropathyGraves’ ophthalmopathyOrbital apex syndromeOrbital decompressionOrbital radiotherapyRituximabThyroid eye diseaseArticle